financetom
Business
financetom
/
Business
/
Tsavorite secures over $100 million in pre-orders for AI chips to scale workflows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tsavorite secures over $100 million in pre-orders for AI chips to scale workflows
Nov 10, 2025 4:42 AM

Nov 10 (Reuters) - AI startup Tsavorite Scalable

Intelligence said on Monday it has secured more than $100

million in pre-orders from enterprises and cloud providers

across the U.S., Asia and Europe to deploy its chips that are

used to scale AI workloads.

The company has seen strong demand for its Omni Processing

Unit (OPU), a compute architecture which unifies central

processing units, graphics processing units, memory and

connectivity in one device, enabling it to be configured to meet

diverse market and application needs.

The growing complexity of artificial intelligence workloads

is driving the industry to scalable solutions that address

challenges such as power consumption, scalability and cost,

facilitating broader adoption of the AI infrastructure.

Tsavorite declined to disclose its current valuation or the

total amount of funding it has raised so far.

Founded by former Intel and chip industry veterans

in 2023, the company expects to deliver its chips and enterprise

class AI appliances capable of supporting all agentic AI

workflows by next year.

"We've built the first truly composable, developer-friendly,

AI platform that delivers step-change gains in efficiency, cost

and scale from edge to hyperscale," CEO Shalesh Thusoo said.

The company is using Samsung's SF4X platform

solution to fabricate the OPU.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
American Express Global Business Travel Clear to Acquire CWT as US DOJ Drops Complaint
American Express Global Business Travel Clear to Acquire CWT as US DOJ Drops Complaint
Jul 29, 2025
03:59 PM EDT, 07/29/2025 (MT Newswires) -- Global Business Travel Group's ( GBTG ) American Express Global Business Travel said Tuesday that the US Department of Justice has dropped its complaint challenging the travel company's takeover of peer CWT. The transaction, valued at $540 million in cash and stock, is now expected to close in Q3, resulting in CWT shareholders...
General Dynamics Insider Sold Shares Worth $1,717,312, According to a Recent SEC Filing
General Dynamics Insider Sold Shares Worth $1,717,312, According to a Recent SEC Filing
Jul 29, 2025
03:56 PM EDT, 07/29/2025 (MT Newswires) -- Rudy F De Leon, Director, on July 28, 2025, sold 5,490 shares in General Dynamics ( GD ) for $1,717,312. Following the Form 4 filing with the SEC, De Leon has control over a total of 5,483 common shares of the company, with 5,483 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/40533/000095017025099603/xslF345X05/ownership.xml Price: 314.12, Change:...
Lilly set for strong quarter after Novo profit warning
Lilly set for strong quarter after Novo profit warning
Jul 29, 2025
(Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook and updates on an experimental obesity drug to gauge the U.S. drugmaker's longer-term health. Lilly's weight-loss drug Zepbound leads the U.S. market and has faced less competition...
Copyright 2023-2026 - www.financetom.com All Rights Reserved